GlycoNet scientist Mariela Segura is developing glycomics-based solutions to improve livestock health.
Catégorie : Points saillants de la recherche
BioLab Business Magazine profile: GlycoNet facilitating glycomics research collaboration and innovation
A network serving the field of glycomics research provides a platform for connections and funding
A new research chair for dementia-causing diseases in children
Thanks to a large donation and the work of GlycoNet researcher and UdeM biochemist Alexey Pshezhetsky, the Elisa Linton Research Chair in Lysosomal Diseases will help treat Sanfilippo disease and similar genetic syndromes.
GlycoNet welcomes three new members to the Board of Directors
Janice Bailey, Jason Acker and Louise St-Onge have joined the GlycoNet Board of Directors
Tiny antibodies could help treat an aggressive type of breast cancer
GlycoNet researchers have developed specialized nanobodies that could enable the immune system to fight triple-negative breast cancer more effectively.
Nobel Prize in Chemistry shines light on glycomics
Congratulations to Drs. Carolyn Bertozzi and Morten Meldal whose groundbreaking work has opened doors in glycomics innovation.
GlycoNet researchers develop new chemical biological tools to monitor Parkinson’s disease
Researchers are a step closer to understanding how Parkinson’s disease develops and progresses.
Engagement and collaboration in action at the 2022 Canadian Glycomics Symposium
Read some highlights from the 2022 Canadian Glycomics Symposium.
Enzymes linked with immune cell activity could hold key to better understanding inflammation
Findings show promise for developing potential new anti-inflammatory drugs and treatments for autoimmune diseases.
Molecules with anti-inflammatory, restorative properties could be key to tackling neurodegenerative disease
GlycoNet researchers are studying a group of molecules that could provide insight into treating and monitoring neurodegenerative diseases.
French 
English